7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Genetic Predisposition to Disease D020022 24 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Lithiasis D020347 2 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Brain Infarction D020520 17 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Spondylarthritis D025241 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Hearing Loss D034381 3 associated lipids
Mastocytoma D034801 3 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Malnutrition D044342 6 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Fractures, Bone D050723 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hypercalciuria D053565 4 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteophyte D054850 2 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Peri-Implantitis D057873 1 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Angina, Stable D060050 2 associated lipids
Vascular Calcification D061205 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Hofbauer LC and Heufelder AE The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. 2001 Arthritis Rheum. pmid:11229454
Leach RJ et al. The genetics of Paget's disease of the bone. 2001 J. Clin. Endocrinol. Metab. pmid:11231972
Hofbauer LC and Heufelder AE [Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases]. 2001 Dtsch. Med. Wochenschr. pmid:11233883
Bolon B et al. Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis. 2001 Mol. Ther. pmid:11237676
Sasaki N et al. Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. 2001 Nephrol. Dial. Transplant. pmid:11239019
Takeuchi T et al. Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells. 2001 Biochem. Pharmacol. pmid:11239501
Mori K et al. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor. 2001 Cell. Immunol. pmid:11243701
Michigami T et al. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma. 2001 Cancer Res. pmid:11245477
Wada N et al. Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: the factor is osteoprotegerin/osteoclastogenesis inhibitory factor. 2001 J. Periodont. Res. pmid:11246705
Lories RJ and Luyten FP Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. 2001 Clin. Rheumatol. pmid:11254237

Table of Content